Pharma Journalist - Page 697 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Evofem Biosciences completes enrollment in Phase 3 Clinical Trial for Amphora

Citius enrolls first patient in Mino-Lok Phase 3 Clinical trial

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results

Tusker Medical enlists first patient for OTTER Study

Intralytix sought FDA clearance to begin Phase I/IIa Clinical Trials for bacteriophages

Regentys collaborates with Cook Biotech to curate Unique Ulcerative Colitis Treatment

Astellas Pharma obtains Universal Cells

Servier and ImmunoQure partner to advance human Interferon-α autoantibody

Spineology finishes enrollment in IDE Trial for Mesh Fusion Transplant